Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: The inter99 study

Diabetes Care

Volumn 32, Issue 3, 2009, Pages 439-444

  Kærch, Kristine ^a   Vaag, Allan ^a   Holst, Jens J ^b   Hansen, Torben ^a   Jøhnsen, Torbeh ^c   Borch Johnsen, Knut ^d  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Research Centre for Prevention and Health   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE COURSE; DISPOSITION INDEX; EARLY PHASE INSULIN RELEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN SENSITIVITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; SCORING SYSTEM;

BLOOD GLUCOSE; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; INSULIN; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 64749108516     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1195     Document Type: Article

References (24)

1. Færch K, Vaag A, Hoist J, Glumer C, Ped-ersen O, Borch-Johnsen K: Impaired fasting glycaemia vs impaired glucose tol-erance: similar impairment of pancreatic a and β cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853-861, 2008
2. Weyer C, Bogardus C, Pratley RE: Meta-bolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197-2203, 1999
3. Laakso M, Zilinskaite J, Hansen T, Boes-gaard T, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Hoist J, Kuulasmaa T, Hribal M, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U, EU-GENE: Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51:502-511,2008
4. Bock G, Man CD, Campioni M, Chittilap-illy E, Basu R, Toffolo G, Cobelli C, Rizza R: Pathogenesis of pre-diabetes: mecha-nisms of fasting and postprandial hyper-glycemia in people with impaired fasting glucose and/or impaired glucose toler-ance. Diabetes 55:3536-3549, 2006
5. Abdul-Ghani MA, Jenkinson CP, Rich-ardson DK, Tripathy D, DeFronzo RA: Insulin secretion and action in subjects with impaired fasting glucose and im-paired glucose tolerance: results from the Veterans Administration Genetic Epide-miology Study. Diabetes 55:1430-1435, 2006
6. Meyer C, Szoke E, Pimenta W, Mitrakou A, Woerle HJ, Gerich J, Van-Haeften T: Different mechanisms for impaired fast-ing glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909-1914, 2006
7. Wasada T, Kuroki H, Katsumori K, Arii H, Sato A, Aoki K, Jimba S, Hanai G: Who are more insulin resistant, people with IFG or people with IGT? Diabetologia 47: 759-760, 2004
8. Hanefeld M, Koehler C, Fuecker K, Hen-kel E, Schaper F, Temelkova-Kurktschiev T: Insulin secretion and insulin sensitiv-ity pattern is different in isolated im-paired glucose tolerance and impaired fasting glucose: the risk factor in im-paired glucose tolerance for atherosclerosis and diabetes study. Diabetes Care 26: 868-874, 2003
9. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabe-tes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl] Med 346:393-403, 2002
11. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Charlotta P: A randomized non-pharmacological inter-vention study for prevention of isch-aemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehab 10: 377-386, 2003
12. Research Centre for Prevention and Health, Glostrup Hospital, Denmark: The Inter99 Study [Internet], 2008. Available from http://www.Inter99.dk. Accessed 14 October 2008
13. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999
14. von Huth Smith L, Borch-Johnsen K, Jør-gensen T: Commuting physical activity is favourably associated with biological risk factors for cardiovascular disease. Eur J Epidemiol 22:771-779, 2007
15. Toft U, Kristoffersen LH, Lau C, Borch-Johnsen K, Jørgensen T: The Dietary Quality Score: validation and association with cardiovascular risk factors: the In-ter99 study. Eur J Clin Nutr 61:270-278, 2006
16. Thomsen TF, Davidsen M, Ibsen H, Jør-gensen T, Jensen G, Borch-Johnsen K: A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRE-CARD and the Copenhagen Risk Score. J Cardiovasc Risk 8:291-297, 2001
17. 0, 120): com-parison with other measures. Diabetes Res Clin Pract 47:177-184, 2000
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Ho-meostasis model assessment: insulin re-sistance and β-cell function from fasting plasma glucose and insulin concentra-tions in man. Diabetologia 28:412-419, 1985
19. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J: Use of the oral glu-cose tolerance test to assess insulin re-lease and insulin sensitivity. Diabetes Care 23:295-301, 2000
20. Williams JW, Zimmet PZ, Shaw JE, De-Court, Cameron AJ, Chitson P, Tuomilehto J, Alberti KGMM: Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius: does sex matter? Diabet Med 20:915-920, 2003
21. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE: Dif-ferences in height explain gender differ-ences in the response to the oral glucose tolerance test - the Aus Diab study. Dia-bet Med 25:296-302, 2008
22. UK Prospective Diabetes Study 16: over-view of 6 years' therapy of type II diabe-tes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 44: 1249-1258, 1995
23. Chang-Chen KJ, Mullur R, Bernal-Mizra-chi E: β-Cell failure as a complication of diabetes. Rev Endocr Metab Disord 9:329-343, 2008
24. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin and proinsu-lin concentrations measured by two oral glucose tolerance tests in a general Cau-casian population: the Hoorn Study. Dia-betologia 39:298-305, 1996